 Perhaps the least-known COVID-19 stock on the market right now is a small Israel-based biotech company called Kamada NASDAQ: KMDA. What is Kamada? Despite having gone public on the NASDAQ in 2013, Kamada is still a pretty small company, with a market cap of less than 400 million. 